Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (161-170 of 333) with videos related to

Pageof 34
Sort By:
Der Internist|May 29, 2020
[Tumor vaccines-therapeutic vaccination against cancer]H-G Rammensee, M W Löffler, J S Walz, et al.
Bone Marrow Transplantation|November 25, 2010
Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patientsS Kobold, J Isernhagen, K Hübel, et al.
World Journal of Urology|August 28, 2002
Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancerM Kuczyk, S Machtens, C Bokemeyer, et al.
Oncology Reports|May 19, 2011
The influence of gemcitabine on the CD4/CD8 ratio in patients with solid tumoursT Daikeler, K Maas, B Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) studyM Aapro, H Ludwig, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinomaC Bokemeyer, B Kynast, A Harstrick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumorsE Grundner-Culemann, C Bokemeyer, V Neubauer, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Pageof 34

Showing results (161-170 of 333) with videos related to

Sort By:
Pageof 34
Der Internist|May 29, 2020
[Tumor vaccines-therapeutic vaccination against cancer]H-G Rammensee, M W Löffler, J S Walz, et al.
Bone Marrow Transplantation|November 25, 2010
Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patientsS Kobold, J Isernhagen, K Hübel, et al.
World Journal of Urology|August 28, 2002
Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancerM Kuczyk, S Machtens, C Bokemeyer, et al.
Oncology Reports|May 19, 2011
The influence of gemcitabine on the CD4/CD8 ratio in patients with solid tumoursT Daikeler, K Maas, B Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) studyM Aapro, H Ludwig, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinomaC Bokemeyer, B Kynast, A Harstrick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumorsE Grundner-Culemann, C Bokemeyer, V Neubauer, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Pageof 34